Switch to Dark

Pricing

Learn

IDXX - IDEXX Laboratories Inc

220

$577.12

-$9.86 (-1.680%)

At close: 3/18/26, 8:00 PM

Score

4.06/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

IDXX

Valuation Score

View as %

Stock Unlock

YTD

Max

Key Data & Metrics

Market Cap

$45.95B

Industry

Health Care

EPS (TTM)

$13.16

P/E (TTM)

43.37

Div & Yield

FCF Payout Ratio

P/S (TTM)

10.68

P/B

28.62

Diluted Shares

80.48M

Ex-Dividend

Next Earnings

04-29

Forward P/E

38.94

Payout Ratio

P/FCF (TTM)

44.03

FCF Yield

2.27%

Earnings Yield

2.31%

52 Week Range

Score Card

Explore Scores Tab

4.06

Good

IDEXX Laboratories Inc has grown revenue at 10.42% over the past year, which is strong growth. Also, it has a free cash flow margin of 24.25%, which suggests the company is very profitable.

Valuation Model

Key Score

2.00

Bad

Management

4.00

Good

Growth

5.00

Very Good

Profitability

4.00

Good

Fin. Health

4.00

Good

Dividends

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form PRE 14A

Unknown Form Type

Filed on 2026-03-13 16:00:48

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 17:01:34

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 17:01:28

Form 4/A

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-03 21:45:20

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-03 16:08:56

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-02 17:00:21

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-27 17:03:27

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-26 16:37:08

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-25 17:48:37

Form 10-K

Annual financials report pursuant to Section 13 or 15(d)

Filed on 2026-02-20 16:09:24

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-19 18:00:27

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-19 18:00:21

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$864.15

49.7%

Avg:

$768.59

33.2%

Low:

$479.96

-16.8%

(% change is relative to the current stock price: $577.12)

Analyst Recommendations

Go to Analyst Tab

4.05

Good

32%

Strong Buy (7)

41%

Buy (9)

27%

Hold (6)

Sell (0)

Strong Sell (0)

About

Website
https://www.idexx.com/
Address
One Idexx Drive, Westbrook MAINE, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=874716

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IPO Date

1991-06-21

Industry

Health Care

Total Employees

11,000

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

Switch to Dark

Pricing

Learn

IDXX - IDEXX Laboratories Inc

220

$577.12

-$9.86 (-1.680%)

4.06/5

Stock Unlock

Key Data & Metrics

Score Card

Good

Insider Transactions

Market News

Form PRE 14A

Filed on 2026-03-13 16:00:48

Form 4

Filed on 2026-03-05 17:01:34

Form 4

Filed on 2026-03-05 17:01:28

Form 4/A

Filed on 2026-03-03 21:45:20

Form 144

Filed on 2026-03-03 16:08:56

Form 4

Filed on 2026-03-02 17:00:21

Form 4

Filed on 2026-02-27 17:03:27

Form 144

Filed on 2026-02-26 16:37:08

Form 144

Filed on 2026-02-25 17:48:37

Form 10-K

Filed on 2026-02-20 16:09:24

Form 4

Filed on 2026-02-19 18:00:27

Form 4

Filed on 2026-02-19 18:00:21

Financials

Price Targets

49.7%

33.2%

-16.8%

Analyst Recommendations

About

Similar Stocks